We are live on ! Find out more
BA

Bard Associates Portfolio holdings

AUM $398M
1-Year Est. Return 54.32%
This Fund
S&P 500
This Quarter Est. Return
+13.9%
1 Year Est. Return
+54.32%
3 Year Est. Return
+200.06%
5 Year Est. Return
+225.83%
10 Year Est. Return
+1,331.15%
AUM
$189M
AUM Growth
+$15.2M
Cap. Flow
+$370K
Cap. Flow %
0.2%
Top 10 Hldgs %
20.77%
Holding
177
New
10
Increased
8
Reduced
117
Closed
3

Sector Composition

Rank Sector Weight
1 Real Estate 16.5%
2 Materials 12.29%
3 Industrials 12.18%
4 Technology 12.08%
5 Healthcare 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBNY
126
DELISTED
Signature Bank
SBNY
$294K 0.16%
2,350
JOF
127
Japan Smaller Capitalization Fund
JOF
$321M
$293K 0.16%
29,922
JYNT icon
128
The Joint Corp
JYNT
$118M
$289K 0.15%
142,150
-6,500
-4% -$20.2K
GDX icon
129
VanEck Gold Miners ETF
GDX
$22.7B
$288K 0.15%
10,395
CGI
130
DELISTED
Celadon Group Inc
CGI
$282K 0.15%
34,563
-2,000
-5% -$19.4K
AGF
131
DELISTED
DB Agriculture Long ETN due April 1, 2038
AGF
$281K 0.15%
22,120
-1,050
-5% -$12.8K
HROW icon
132
Harrow
HROW
$1.45B
$246K 0.13%
65,500
XTNT icon
133
Xtant Medical Holdings
XTNT
$60.3M
$244K 0.13%
10,631
-523
-5% -$13.5K
ICLR icon
134
Icon
ICLR
$12.6B
$238K 0.13%
3,400
-500
-13% -$34.3K
FMO
135
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$226K 0.12%
3,271
+200
+7% +$12.7K
GLD icon
136
SPDR Gold Trust
GLD
$131B
$223K 0.12%
1,766
JJSF icon
137
J&J Snack Foods
JJSF
$1.43B
$215K 0.11%
+1,800
New +$191K
QCLS
138
Q/C Technologies Inc
QCLS
$20.5M
0
IIN
139
DELISTED
IntriCon Corporation
IIN
$211K 0.11%
+39,500
New +$227K
GLAD icon
140
Gladstone Capital
GLAD
$422M
$209K 0.11%
14,425
-100
-0.7% -$1.46K
AUY
141
DELISTED
Yamana Gold, Inc.
AUY
$208K 0.11%
40,011
-6,504
-14% -$29.2K
CPT icon
142
Camden Property Trust
CPT
$11B
$204K 0.11%
+2,308
New +$193K
SNAK
143
DELISTED
Inventure Foods, Inc.
SNAK
$203K 0.11%
25,950
-1,000
-4% -$7.06K
CGO
144
Calamos Global Total Return Fund
CGO
$125M
$202K 0.11%
18,525
GPX
145
DELISTED
GP Strategies Corp.
GPX
$201K 0.11%
9,250
LOAN
146
Manhattan Bridge Capital
LOAN
$47.5M
$198K 0.1%
+37,250
New +$166K
TOVX icon
147
Theriva Biologics
TOVX
$9.64M
$181K 0.1%
12
ANIX icon
148
Anixa Biosciences
ANIX
$116M
$176K 0.09%
56,000
-4,800
-8% -$14.6K
CGNT
149
DELISTED
Cogentix Medical, Inc.
CGNT
$167K 0.09%
173,930
-9,952
-5% -$9.82K
RLOG
150
DELISTED
Rand Logistics, Inc.
RLOG
$146K 0.08%
141,695
-10,010
-7% -$9.88K

Similar funds

Bard Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Bard Associates held 177 positions worth $189M, up 8.7% from $174M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Bard Associates's Q2 2016 filing shows 10 new, 8 increased, 117 reduced and 3 closed positions. Its largest new stake was Global Water Resources: 169,600 shares worth $1.49M. The largest sale was NeoGenomics, an estimated $196K.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, up from 16% a quarter earlier, followed by Materials and Industrials.

  • Bard Associates's largest Q2 2016 buy was Global Water Resources: 169,600 shares worth $1.49M.
  • Bard Associates added most to Truett-Hurst, Inc. Class A Common Stock in Q2 2016, an estimated $224K increase.
  • Bard Associates's biggest Q2 2016 reduction was NeoGenomics, cutting an estimated $196K.
  • Bard Associates fully exited DAKOTA PLAINS HOLDINGS, INC. COMMON STOCK in Q2 2016, selling an estimated $1K.
  • Bard Associates's ten largest holdings make up 21% of its $189M portfolio in Q2 2016.
  • Bard Associates opened 10 new positions and closed 3 in Q2 2016.
  • Bard Associates's portfolio value rose 8.7% quarter-over-quarter to $189M.

Based on Bard Associates's 13F filing for Q2 2016, filed 11 Aug 2016.